Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Eatwell nutrition program to improve diets linked to cancer prevention

Official title: Efficacy of a Multi-level Intervention Designed to Promote Adherence to WCRF/AICR Dietary Guidelines for Cancer Prevention

Run by Drexel University · NCT07225881 · Data updated 2026-11-12

This trial will test whether the Eatwell program helps adults with low adherence to cancer-prevention dietary guidelines eat more fruits, vegetables and whole grains and cut back on processed foods, red/processed meat, and sugary drinks.

More HIV Prevention trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment472 (estimated)
SponsorDrexel University
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedFebruary 10, 2026
Main results expectedOctober 31, 2029
Study endsApril 30, 2030
Registry record updatedMarch 16, 2026
Trial IDNCT07225881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who live with another adult, have low adherence to WCRF/AICR cancer-prevention dietary guidelines, can read and speak English, have the technology to join virtual sessions, are willing to be randomized and attend sessions, and can provide blood samples at a partner lab are ideal candidates.

Probably not a fit

People who already meet the cancer-prevention dietary guidelines, cannot attend intervention sessions or lab visits, lack the required technology, or cannot participate in household-based changes are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, two-arm trial will enroll 236 index adults plus 236 adult household members (N=472) who score low on WCRF/AICR dietary guidelines and randomize them to the Eatwell intervention or traditional nutrition education. The Eatwell program focuses on healthier grocery choices, eating at home more often, and strategies for handling temptations when eating out, delivered via sessions and monthly emails with household support. The primary outcome is a total dietary adherence score calculated using NCI's standardized scoring system, with secondary outcomes including grams/day of fruits, vegetables, and fiber; percent of calories from ultra-processed foods; grams/week of red and processed meat; grams/day of sugar-sweetened beverages; and biomarkers of inflammation measured from blood draws. Participants will need technology for videoconferencing and must be willing to provide blood samples at a partnered commercial laboratory.

Why it matters

Potential benefit: If successful, the Eatwell approach could help people adopt dietary patterns linked to lower cancer risk and improve inflammation-related biomarkers.

How similar studies have gone: Prior lifestyle and nutrition interventions have produced modest improvements in diet quality and some biomarkers, and the Eatwell program builds on that literature with a household-focused approach that is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or older
* Access to technology necessary to receive emails and join videoconferencing meetings
* Ability to read and speak English
* Willingness to be randomized to either study condition, including ability and willingness to attend intervention sessions
* Ability and willingness to attend intervention sessions, receive monthly email messages, and serve in support role if index participant in household is assigned to Eatwell condition
* Able and willing to visit a commercial laboratory partnered with this project (e.g., Labcorp) in order to have their blood drawn at the time of study visits
* Low adherence to WCRF/AICR's four dietary guidelines (operationalized as a level of intake, based on brief self-report questions administered during phone screening, that corresponds to a score of 2 or less in the Shams-White method of dietary adherence scoring)
* Share a household (i.e., a private residence with a shared living space, including kitchen) with an adult who provides informed consent, meets eligibility criteria, and anticipates remaining in this household for the majority of the next 18 months
* Agree that they will not join another intervention study run by this study team in the next 18 months
* Successful completion by self and household member of all enrollment and baseline data collection tasks
* Have an email that they regularly check and willingness to use that for corresponding to study staff
* Weight at baseline of 396 lbs or less, as the digital scales used for measurement are not able to obtain measurements for weights higher than this

Exclusion Criteria:

* A medical or psychiatric condition, including self-reported history of anorexia nervosa or bulimia nervosa, that may limit appropriateness of or ability to comply with dietary recommendations
* A psychiatric condition, including self-reported history of anorexia nervosa or bulimia nervosa, that may make it difficult or inappropriate for household member to serve in support role
* Currently taking medication that can substantively change appetite or eating behavior, including using of a GLP-1 medication
* Planning to enroll in another lifestyle modification program in the next 18 months
* History of bariatric surgery
* Currently pregnant or planning to become pregnant in the next 18 months
* Type 1 Diabetes

Where it's running

  • Drexel University
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.